Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(67%)
Terminated
1(33%)

Phase Distribution

Ph phase_1
1
33%
Ph not_applicable
2
67%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting267%
terminated133%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Core Semantic Systems TMS

NCT06870552
recruitingphase_1

Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke

NCT06365099
terminatednot_applicable

Glucose and Non-Invasive Brain Stimulation

NCT04031404

Clinical Trials (3)

Showing 3 of 3 trials
NCT06870552Not Applicable

Core Semantic Systems TMS

Recruiting
NCT06365099Phase 1

Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke

Recruiting
NCT04031404Not Applicable

Glucose and Non-Invasive Brain Stimulation

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3